Asit Parikh

Asit Parikh

Direttore/Membro del Consiglio presso PHATHOM PHARMACEUTICALS, INC.

Patrimonio netto: 364 000 $ in data 30/04/2024

52 anni
Health Technology
Consumer Services

Provenienza dei contatti di primo grado di Asit Parikh

EntitàTipo di entitàSettore Industriale
Public Company Pharmaceuticals: Major 52
Public Company Pharmaceuticals: Major 22
6
Holding Company Pharmaceuticals: Major 6
5
Holding Company Biotechnology 5

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Asit Parikh tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Investment Managers

Charles Homcy

Jeffrey Tong

Jeffrey Finer

Reid Huber

Christoph S. Lengauer

Walter Kowtoniuk

Ronald Park

Consultant / Advisor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Analyst

Corporate Officer/Principal

Stanford University College/University

Tadataka Yamada

James Topper

David Socks

Jennifer Cook

Shinji Honda

Jeffrey Finer

Ronald Park

Undergraduate Degree

Corporate Officer/Principal

Masters Business Admin

Graduate Degree

Graduate Degree

Doctorate Degree

Doctorate Degree

ABBOTT LABORATORIES Medical Specialties

Olivier Jean Bohuon

Roger Ulrich

Mark Stenhouse

Azmi Nabulsi

Tom Harris

Ramy Riad

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Tadataka Yamada

Anna Protopapas

Shinji Honda

Andrew Plump

Ralf Clemens

Ronald Law

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

President

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Massachusetts Institute of Technology College/University

Anna Protopapas

Jeffrey Finer

Andrew Plump

Aditya Kohli

Cosmas Giallourakis

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Undergraduate Degree

Investment Managers

Tadataka Yamada

James Topper

David Socks

Roger Ulrich

Aditya Kohli

Private Equity Analyst

Private Equity Investor

Private Equity Investor

Consultant / Advisor

Private Equity Analyst

SANOFI Biotechnology

Ian Clark

François-Xavier Roger

Jeffrey Albers

Andrew Plump

Sales & Marketing

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

SHIRE Pharmaceuticals: Major

Ian Clark

Steven Gillis

Olivier Jean Bohuon

Gisele Dion

Director/Board Member

Director/Board Member

Director/Board Member

Comptroller/Controller/Auditor

PFIZER, INC. Pharmaceuticals: Major

Padma Thiruvengadam

James J. O'Leary

Timothy Sullivan

Larry Miller

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

General Counsel

Pharmaceuticals: Major

Charles Homcy

James Topper

Anna Protopapas

Hiromichi Kimura

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Corporate Officer/Principal

Medical Specialties

Kathryn Corzo

Jeffrey Albers

Jessica Sachs

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Tadataka Yamada

David Socks

Aditya Kohli

Chairman

Chief Executive Officer

Founder

PASSAGE BIO, INC. Biotechnology

Tadataka Yamada

David Socks

Aditya Kohli

Founder

Founder

Founder

Harvard College College/University

Jeffrey Tong

Stephen Brannan

Ronald Park

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

TOKYO ELECTRIC POWER COMPANY HOLDINGS, INC. Electric Utilities

Yoshiaki Fujimori

Yasuchika Hasegawa

Fumio Sudo

Director/Board Member

Director/Board Member

Chairman

Miscellaneous Commercial Services

Charles Homcy

Jeffrey Tong

Jeffrey Finer

Founder

Director/Board Member

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Michel Orsinger

Kleem Chaudhary

George Apostol

President

Corporate Officer/Principal

Corporate Officer/Principal

Harvard Medical School College/University

Charles Homcy

Jeffrey Tong

Michael Mendelsohn

Corporate Officer/Principal

Graduate Degree

Doctorate Degree

Miscellaneous Commercial Services

Ian Clark

Jeffrey Tong

Reid Huber

Director/Board Member

Director/Board Member

Director/Board Member

CELGENE Biotechnology

Terrie Curran

Joe Hand

Martin J. Gilligan

Corporate Officer/Principal

Human Resources Officer

Corporate Officer/Principal

Georgetown University College/University

Heidi Fields

David Socks

Jeffrey Albers

Undergraduate Degree

Undergraduate Degree

Graduate Degree

MERCK & CO., INC. Pharmaceuticals: Major

Andrew Plump

Terrie Curran

Christopher J Morabito

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

BLUEPRINT MEDICINES CORPORATION Biotechnology

Christoph S. Lengauer

Jeffrey Albers

Thilo Schroeder

Chief Tech/Sci/R&D Officer

Chairman

Director/Board Member

Pharmaceuticals: Major

Tadataka Yamada

Christoph S. Lengauer

Director/Board Member

Director/Board Member

GYROSCOPE THERAPEUTICS HOLDINGS PLC Biotechnology

Ian Clark

Jennifer Cook

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Ian Clark

Steven Gillis

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Tadataka Yamada

David Socks

Founder

Founder

The Trustees of Columbia University in The City of New York College/University

Charles Homcy

Melissa Palmer

Corporate Officer/Principal

Undergraduate Degree

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Charles Homcy

James Topper

Chief Executive Officer

Founder

Pharmaceuticals: Major

Tadataka Yamada

Mark Stenhouse

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Charles Homcy

Ai Min Hui

Director/Board Member

Chief Tech/Sci/R&D Officer

Biotechnology

Charles Homcy

Jennifer Cook

Director/Board Member

Director/Board Member

The Johns Hopkins University College/University

Charles Homcy

Christoph S. Lengauer

Director/Board Member

Masters Business Admin

CYTOKINETICS, INCORPORATED Pharmaceuticals: Major

Charles Homcy

Jeffrey Finer

Director/Board Member

Private Equity Investor

BRIDGEBIO PHARMA, INC. Biotechnology

Charles Homcy

Jennifer Cook

Founder

Director/Board Member

Dartmouth College College/University

Steven Gillis

Larry Miller

Doctorate Degree

Undergraduate Degree

RELAY THERAPEUTICS, INC. Biotechnology

Charles Homcy

Christoph S. Lengauer

Founder

Director/Board Member

PROMETHEUS BIOSCIENCES, INC. Biotechnology

Tadataka Yamada

Mark Stenhouse

Chairman

Chief Operating Officer

AGILENT TECHNOLOGIES, INC. Medical Specialties

Heidi Fields

Tadataka Yamada

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Yasuchika Hasegawa

Shinji Honda

President

Corporate Officer/Principal

Pharmaceuticals: Major

Roger Ulrich

Michael Mendelsohn

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

College/University

Azmi Nabulsi

George Apostol

Graduate Degree

Graduate Degree

University of Notre Dame College/University

Timothy Sullivan

Joe Hand

Undergraduate Degree

Undergraduate Degree

BIOGEN INC. Pharmaceuticals: Major

Gisele Dion

Kleem Chaudhary

Comptroller/Controller/Auditor

Corporate Officer/Principal

University of California, Berkeley College/University

Aditya Kohli

Timothy Sullivan

Doctorate Degree

Doctorate Degree

The University of North Carolina at Chapel Hill College/University

Jonathan Edwards

Kleem Chaudhary

Doctorate Degree

Doctorate Degree

CYCLERION THERAPEUTICS, INC. Pharmaceuticals: Major

Michael Mendelsohn

Larry Miller

Director/Board Member

General Counsel

Pharmaceuticals: Major

Michael Mendelsohn

Christopher J Morabito

Founder

Chief Tech/Sci/R&D Officer

Statistiche

Distribuzione geografica

Stati Uniti 46
Francia 2
Irlanda 2
Giappone 2
Svizzera 2

Settori

Health Technology 33
Consumer Services 12
Finance 4
Commercial Services 4
Utilities 2

Posizioni

Director/Board Member 367
Corporate Officer/Principal 204
Independent Dir/Board Member 116
Chairman 80
Undergraduate Degree 62
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA